Jun 1, 2020

How telemedicine can be a silver bullet post-COVID-19

King's College Hospital London...
4 min
Telemedicine is an established health-tech service line but one that is not very widespread or commonly utilized by most healthcare facilities
In March, the World Health Organization (WHO) declared COVID-19 a global pandemic. In many countries including the UAE, a stay at home order was impleme...

In March, the World Health Organization (WHO) declared COVID-19 a global pandemic. In many countries including the UAE, a stay at home order was implemented and a big number of industries were affected as a result, including the healthcare industry. However, this restriction of movement saw a need to adopt new ways of service delivery or expand the existing but less-used service lines.

Since the onset of COVID-19, the healthcare industry, which is at the axis of the pandemic, experienced a drop in elective surgeries, medical tourism and outpatient department footfall among others. This drop saw an exponential boom in telemedicine, which is an established health-tech service line but one that is not very widespread or commonly utilized by most healthcare facilities. Healthcare providers have since adopted and deployed this model of service delivery to patients, and it seems that as long as COVID-19 is still around, tele-health’s popularity will continue to rise.

The question that begs to be answered is, will this surge in tele-consultations and telemedicine be sustainable post COVID-19 pandemic or will it retreat into obscurity only to appear when the need arises? Well, not only can it be sustained, but it can be a game-changer in patient engagement. After all, telemedicine was here before COVID-19, and it’s here to stay, only this time it is being boosted by the pandemic.

Telemedicine Has Been Around for Decades

According to the American Telemedicine Association (ATA), Telemedicine is the remote delivery of health care services and clinical information using telecommunications technology.  This includes a wide array of clinical services using internet, wireless, satellite and telephone media. And in reference to research, it has been around for more than 40 years, with radiology being one of the first specialties to fully embrace it back in the 1980s. So, if tele-health worked then, why can’t it work post COVID-19, considering todays ease of access to the information superhighway?

Integration of Telehealth into Other Services

At King’s in Dubai, telemedicine has become an integral service line, and it is available for all specialties. After the COVID-19 pandemic, we will continue investing, upgrading and using advanced telemedicine solutions, at least for no-emergency and non-life-threatening cases. Patients will continue to have access to reliable medical care from diagnostics and treatment to online prescriptions from the comfort of their home, and at their convenience.

This means that the patient will not need to have an on-site clinical visit if it’s not necessary. In the long run, this can be a win-win for both the patient and the healthcare facility in terms of saving time and overhead expenses. The patient will have the choice on how to interact with his Doctor or other clinical staff. Often a physical exam is needed. However, for follow-up visits e.g. in Endocrinology, the patient may well choose to conduct the consultation from the comfort of his home. Healthcare providers are opening up their channels on how patients can avail our services. The pandemic boosted the tele-consult as it helps patients to stay-at-home.

Home Healthcare and Integrated Value Chain of Delivery of Services

As promising as it sounds, tele-health on its own may not be enough and for it to thrive, it has to be integrated into other services like home healthcare, where the physician goes to the patient’s home to provide the needed medical services including routine checkups, administering medication and collection of medical samples for diagnostic purposes. Fully integrated patient records allows clinicians to serve the patients best, no matter whether they present physically or remotely. Home delivery of prescribed medications adds to the safety and convenience for the patients. 

More Personalized and Quality Care

Over the years, studies have indicated more patient satisfaction with tele-health services. Although it might appear tele-health creates a distance/barrier when it comes to patient-doctor relationship, these studies have shown that it actually improves this relationship, with high degrees of satisfaction, especially as it gives patients fast and seamless access to their trusted clinician.

An Integral Part of the Healthcare System

While tele-health is a good addition to other healthcare services in the current COVID-19 situation, it is only as good if it is integrated within the whole healthcare service plan. If this is effectively implemented, in the foreseeable future we will see people actually opting for tele-health as opposed to going to the doctor’s office, which will result in a positive shift on how convenient health care is given and received in the long term.

Telemedicine at King’s and Access to World Class Expertise

Telehealth at King’s in Dubai provides access to subspecialties at our mothership facility at King’s College Hospital in the UK for different specialties. For instance, the Radiology department here in Dubai has access to more than 500 specialists in London, with access to the latest diagnostic solutions and techniques. Equally telemedicine allows us to real-time connect with world-leading experts at King’s in London while the patient has his consultation here in Dubai and get their opinion. The same applies for all complex cases where established multi-disciplinary teams discuss the best treatment options and allows us to have access to outstanding expertise from both Doctors here in Dubai as well as London. Telemedicine brings the world of clinical know-how closer together and ensures that no matter where in the world you are, access to the leading experts can be facilitated.

By King's College Hospital London in Dubai

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article